Daewoong pharmaceutical Co.,Ltd (069620.KS) KSC

182,500.00

+2300(+1.28%)

Updated at December 05 12:14PM

Currency In KRW

Valuation

Market Cap1.45T
Enterprise Value2T
P/E Ratio27.61
PEG Ratio0.29
Price/Sales Ratio1.39
Price/Book Ratio2.49
Enterprise/Revenue1.78
Enterprise/EBITDA16.03

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.05
Operating Margin0.12

Management Effectiveness

Return On Assets0.04
Return On Equity0.09

Income Statement

Revenue1.42T
Revenue/Share129,360.32
Gross Profit734.17B
EBITDA112.52B
Net Income24.73B
Diluted EPS2,149.85

Balance Sheet

Total Cash164.23B
Total Cash/Share14,275.06
Total Debt733.58B
Total Debt/Equity0.88
Current Ratio1.11
Book Value Per Share82,906.91

Price History

52-Week Change44.97
52-Week High183,700
52-Week Low109,000
Moving Average 50 Days148,640
Moving Average 200 Days142,211.5

Statistics

Average Volume50,814
Shares Outstanding11.51M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate600
Trailing Annual Dividend Yield0.33
Payout Ratio0.1
Last Split Factor103:100
Last Split DateDecember 27, 2012